Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease - Concepedia

Concepedia

Publication | Open Access

Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease

DOI Full Paper Access

277

Citations

41

References

2010

Year

Adam J. Smith, Brian Giunta, Paula C. Bickford, Michael W. Fountain, Jun Tan, R. Douglas Shytle

International Journal of Pharmaceutics

NanomedicineNeurodegenerative DiseasesAlzheimer's DiseaseBiochemistryMedicineα-Secretase Inducing AbilityNanolipidic ParticlesNeurochemical BiomarkersProtein MisfoldingPharmacology

References

	Year	Citations

Page 1